The MADIT-ICD benefit score is proposed as a novel tool to personalize the assessment of prophylactic ICD benefit by weighing VT/VF risk against non-arrhythmic mortality.
Requires prospective validation before guiding ICD decisions; leaves open the benefit of personalized prophylactic ICD assessment.
We propose the novel MADIT-ICD benefit score that predicts the likelihood of prophylactic ICD benefit through personalized assessment of the risk of VT/VF weighed against the risk of non-arrhythmic mortality.
No takes yet. Share an insight, caveat, or question.
Younis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: